Web14 nov. 2024 · Lyon & Caen, France, 14 November 2024 – Lys Therapeutics, a French biotechnology company developing innovative therapies for neurovascular and … Web🎂🕯️🕯️2 years today!! What an amazing #team behind the scenes of Lys Therapeutics!! 👉🏻Fanny Potzeha, Flavie Lesept, Jean-Baptiste BERTRAND, Werner…
Congresses and events - Lys Therapeutics
WebLys Therapeutics is a biotechnology company developing drugs to treat patients suffering from neurovascular or neurodegenerative disorders. The company's main drug is a monoclonal antibody, Glunozumab, displaying an exclusive and groundbreaking mechanism of action, that triggers off-target toxicity through hyperactivation of both vascular and. WebA novel biotherapy targeting the blood-brain barrier dysfunctions to treat patients suffering from disabling neurological diseases . Lys Therapeutics, a French biotech company developing innovative treatments for neurological and neurodegenerative diseases, announced today its first fundraising of 5.5 million euros. chemistry vs pharmacology
Full List of Pharmaceutical Companies in France (2024)
WebSetting up of a new production team and industrialisation of therapeutic vaccines against different cancers. Manufacturing of clinical batches including on going phase III. These … Web21 oct. 2024 · LYS THERAPEUTICS à Lyon - L’annuaire Hoodspot - Adresse, numéro de téléphone, produits et services de LYS THERAPEUTICS. Contacter par courrier à … WebLocation Lyon, Rhone-Alpes, France. CB Rank (Hub) 18,385. Number of Founders 493. Average Founded Date Sep 12, 2002. Percentage Acquired 6%. Percentage Non-Profit 2%. Number of For-Profit Companies 1,477. Number of Non-profit Companies 24. Top Investor Types Venture Capital , Accelerator , Private Equity Firm , Investment Bank , Angel Group. chemistry vs physics vs biology